Skip to main content

Table 1 Cannabis patterns of use by decade in community-based athletes

From: Age related differences in cannabis use and subjective effects in a large population-based survey of adult athletes

Pattern of use

Category

21 to 29 (n = 47)

30 to 39 (n = 74)

40 to 49 (n = 81)

50 to 59 (n = 61)

≥60 (n = 38)

P value for trend

N (%)

Cannabinoid used

THC

10 (21.3)

19 (25.7)

16 (19.8)

10 (16.4)

6 (15.8)

0.21

CBD

9 (19.1)

16 (21.6)

27 (33.3)

28 (45.9)

21 (55.3)

< 0.001

THC and CBD

28 (59.6)

39 (52.7)

38 (46.9)

23 (37.7)

11 (28.9)

0.009

Reason for use

Medical

4 (8.5)

15 (20.3)

28 (34.6)

31 (50.8)

21 (55.3)

< 0.001

Recreational

21 (44.7)

23 (31.1)

23 (28.4)

15 (24.6)

5 (13.2)

0.002

Both

22 (46.8)

36 (48.6)

30 (37.0)

15 (24.6)

12 (31.6)

0.004

Duration

> 3 years

30 (63.8)

41 (55.4)

37 (45.7)

21 (34.4)

18 (47.4)

< 0.001

Frequency

≥4 times/week

12 (25.5)

39 (52.7)

33 (40.7)

20 (32.8)

13 (34.2)

0.20

Routes of administration

Edible

31 (66.0)

38 (51.4)

46 (56.8)

18 (29.5)

14 (36.8)

< 0.001

Vaporize

25 (53.2)

34 (45.9)

28 (34.6)

14 (23.0)

8 (21.1)

< 0.001

Smoke

23 (48.9)

35 (47.3)

26 (32.1)

15 (24.6)

8 (21.1)

< 0.001

Oil/tincture

17 (36.2)

24 (32.4)

35 (43.2)

31 (50.8)

23 (60.5)

0.003

Topical

15 (31.9)

23 (31.1)

29 (35.8)

22 (36.1)

13 (34.2)

0.57

Capsule

7 (14.9)

8 (10.8)

13 (16.0)

10 (16.4)

1 (2.6)

0.51

Spray

2 (4.3)

5 (6.8)

3 (3.7)

3 (4.9)

1 (2.6)

0.57

Routes of administration

Edible

31 (66.0)

38 (51.4)

46 (56.8)

18 (29.5)

14 (36.8)

< 0.001

Vaporize

25 (53.2)

34 (45.9)

28 (34.6)

14 (23.0)

8 (21.1)

< 0.001

Smoke

23 (48.9)

35 (47.3)

26 (32.1)

15 (24.6)

8 (21.1)

< 0.001

Oil/tincture

17 (36.2)

24 (32.4)

35 (43.2)

31 (50.8)

23 (60.5)

0.003

Topical

15 (31.9)

23 (31.1)

29 (35.8)

22 (36.1)

13 (34.2)

0.57

Capsule

7 (14.9)

8 (10.8)

13 (16.0)

10 (16.4)

1 (2.6)

0.51

Spray

2 (4.3)

5 (6.8)

3 (3.7)

3 (4.9)

1 (2.6)

0.57

Timing of use

Within 1 h before starting exercise

14 (29.8)

25 (33.8)

21 (25.)

13 (21.3)

6 (15.8)

< 0.001

During exercise

2 (4.3)

7 (9.5)

9 (11.1)

6 (9.8)

3 (7.9)

0.53

Within 1 h after finishing exercise

21 (44.7)

37 (50.0)

21 (25.9)

13 (21.3)

8 (21.1)

< 0.001